GL Maintained by Morgan Stanley -- Price Target Raised to $208
Morgan Stanley has maintained an "Overweight" rating on Globe Life (GL) and increased its price target to $208 from $181, reflecting a positive outlook. Despite this, GuruFocus indicates GL is 19.5% overvalued at its current price of $179.33, with significant insider selling totaling $30.8 million over the last three months. While GL boasts a strong GF Score™ of 89/100, driven by excellent growth potential, investors are advised to exercise caution due to the overvaluation and insider activity.
3 Unpopular Stocks We Approach with Caution
This article identifies three "unpopular" stocks—CSX, Globe Life, and NBT Bancorp—that Wall Street analysts have issued cautious forecasts for. The author suggests that the bearish calls are justified based on analyses of their financial performance, such as flat sales, decreasing profitability, and slow growth. For each company, specific financial metrics are highlighted to explain the low confidence, and the article concludes by suggesting alternative investment opportunities with stronger momentum.
Globe Life Inc. Stock 12‑Month Price Target Raised to $181.08
Analysts have raised the 12-month average price target for Globe Life Inc. stock from $178.83 to $181.08, with forecasts spanning $147 to $215 per share. Despite the increase, the consensus rating for GL from 14 analysts remains a "Buy," with 10 recommending a Buy, 4 a Hold, and no Sells. Investors can find more detailed price target data and analyst recommendations on TradingView's Forecasts tab and News Flow.
Globe Life highlights its insurance franchise as investors weigh the long-term growth story
Globe Life Inc. operates a significant life and supplemental health insurance franchise in the U.S., with investors closely monitoring its policy growth, underwriting discipline, and capital strength for long-term prospects. The company's business model relies on recurring premium income and investment returns, with distribution efficiency and robust risk management being key performance drivers. Globe Life competes in a diversified market by focusing on accessible life and health policies that provide financial protection, making it an interest-rate-sensitive stock influenced by broader macroeconomic conditions.
Globe Life term life insurance from Globe Life - low-entry coverage focus for US families
Globe Life offers term life insurance focused on low-entry coverage amounts, starting around $5,000, for US families. The policies feature simplified underwriting, fixed premiums for the term, and do not build cash value, making them suitable for budget-conscious buyers primarily seeking death benefit protection for specific financial obligations. Globe Life employs direct mail, online platforms, and agents for sales, and its term life products contribute to the company's broader life and health insurance portfolio, which is traded on the NYSE under the symbol GL.
Globe Life’s Bigger Credit Facility: What Does It Reveal About GL’s Evolving Capital Allocation Strategy?
Globe Life Inc. recently expanded its credit facility by increasing its term loan capacity and extending debt maturities, reinforcing its financial flexibility. This move supports ongoing operational and capital allocation plans, aligning with its strategy of steady underwriting, investment income, and disciplined capital returns, and could influence its investment narrative, especially given its raised 2026 earnings guidance and ongoing share buybacks. However, investors should remain aware of ongoing investigations and regulatory pressures that could impact future targets.
Globe Life’s Bigger Credit Facility: What Does It Reveal About GL’s Evolving Capital Allocation Strategy?
Globe Life Inc. recently expanded its credit facility and term loan capacity, extending maturities to 2029 and 2031, which bolsters its financial flexibility for operations and capital deployment. This move supports its strategy focused on steady underwriting, investment income, and disciplined capital returns, although it doesn't change the immediate focus on earnings delivery and existing regulatory pressures. Investors should consider how this increased financial flexibility aligns with management's stated capital allocation priorities while keeping an eye on ongoing investigations and execution challenges.
Globe Life focuses on insurance fundamentals as investors weigh long-term growth
Globe Life Inc. continues to operate as a steady life and supplemental health insurer focused on middle-income households. The company emphasizes protection-oriented policies and recurring premium revenue, with earnings driven by premium growth, investment income, and expense management. Investors assess Globe Life stock based on its ability to balance growth, capital management, and shareholder returns within the competitive US equity market.
Lincoln National (NYSE:LNC) - Stock Analysis
This report provides a comprehensive stock analysis of Lincoln National (NYSE:LNC), detailing its valuation, future growth prospects, past performance, financial health, and dividend information. It highlights the company's current valuation at 64% below fair value and a dividend yield of 4.86%, while also noting risks such as significant insider selling and dividend coverage issues. Recent news includes upcoming dividend payments, management changes, new product launches in annuities and universal life insurance, and mixed analyst sentiment on its future performance.
Price to earnings forward of Globe Life Inc. – NYSE:GL
The article provides a financial snapshot for Globe Life Inc. (NYSE: GL), specifically focusing on its forward price-to-earnings ratio. It seems to be a data point from a financial platform like TradingView, indicating a period value, change, and percentage change for this metric. The content itself, however, has no actual figures.
Globe Life highlights insurance portfolio as investors weigh long-term growth prospects
Globe Life Inc. is an insurance holding company focusing on life and supplemental health coverage, valued for its long-duration cash flow profile. The company's business model relies on stable recurrence of premiums and strong customer retention, supported by a diverse product portfolio and conservative capital management. Investors prioritize Globe Life's long-term financial strength, underwriting discipline, and its ability to meet policyholder obligations while providing shareholder returns.
Globe Life (GL) Could Be 50% Undervalued Following Earnings Optimism
Globe Life (GL) is experiencing investor optimism ahead of its second-quarter earnings, with expectations of double-digit profit growth. While one valuation model suggests the stock is slightly overvalued at $172.10, a discounted cash flow analysis implies it could be significantly undervalued, trading at a large discount to an estimated future cash flow value of $360.56. Investors are encouraged to review both perspectives and consider the company's planned Bermuda reinsurance affiliate, which is expected to boost free cash flow and financial flexibility.
Globe Life balances growth and risk in the US insurance market
Globe Life Inc. navigates the competitive US life and supplemental health insurance market by focusing on disciplined underwriting, cost control, and targeting middle-income families with affordable protection products. The company utilizes a multi-channel distribution strategy and manages risks like mortality and investment volatility under state-based regulations. Investors assess Globe Life based on its balance of growth, risk management, and capital deployment strategies, against a backdrop of demographic shifts and economic conditions.
General Dynamics Corporation $GD Shares Acquired by Hsbc Holdings PLC
Hsbc Holdings PLC significantly increased its stake in General Dynamics (NYSE:GD) during the fourth quarter, acquiring an additional 344,722 shares to bring its total to 983,862 shares valued at approximately $331.3 million. This move comes as several analysts have issued positive ratings for GD, contributing to a "Moderate Buy" consensus. The company also reported strong Q1 results, exceeding revenue and EPS estimates, and declared a quarterly dividend of $1.59 per share.
Globe Life Inc operations and strategy context. Insurance stock perspective for long-term investors
Globe Life Inc. operates as a U.S.-based life and health insurer, focusing on individual policies and a long-term strategy built on stable underwriting, disciplined capital allocation, and a dedicated agent network. The company emphasizes consistent underwriting standards, conservative reserving, and predictable protection products, targeting middle-income families. Globe Life's operational discipline aims to generate sustainable cash flows by balancing growth with prudence, while its stock reflects future earnings, capital strength, and growth prospects for long-term investors.
PRI - Primerica Inc Options
This article provides comprehensive financial data for Primerica Inc (PRI), including its latest stock performance, key financial metrics like market cap, income, and sales, and various valuation ratios. It also details insider and institutional ownership, profitability, and EPS and sales growth. The company's options trading availability and recent dividend information are also highlighted.
Globe Life stock holds near $? as filings stay central
Globe Life Inc. (US37959E1029) is a NYSE-listed insurer focusing on individual life and supplemental health coverage. The company's business model emphasizes premium growth, underwriting discipline, and policy persistency, with its core appeal stemming from insurance cash flow, regulated operations, and a US-listed equity story tied to earnings quality and capital management. This article reviews its company profile and listing context, noting that share price information was not available in the search results.
Globe Life Extends Maturity Dates of Credit Agreements
Globe Life Inc. announced the extension of the maturity dates for its $1,050,000,000 multi-currency revolving credit agreement to June 2029 and its $350,000,000 term loan credit agreement to June 2028. These extensions provide the company with continued financial flexibility and stability.
Globe Life EVP Skarjune sells $331,483 in stock
Dolores L. Skarjune, EVP and Chief Administrative Officer of Globe Life Inc., sold 1,850 shares of company stock for $331,483 after acquiring them through employee stock options. This transaction occurred while Globe Life shares were near their 52-week high, following a 45% return over the past year. Analysts have varied price targets for GL, with some raising estimates and maintaining positive ratings.
Form 4 Globe Life Inc For: 30 June By Investing.com
This article announces the filing of a Form 4 for Globe Life Inc. for the period ending June 30. It includes the stock symbol GL and a minor price change, indicating routine financial disclosure. The content is brief and primarily serves as a notification without detailed analysis.
Globe Life EVP Skarjune sells $331,483 in stock By Investing.com
Dolores L. Skarjune, Executive Vice President of Globe Life Inc. (NYSE:GL), sold 1,850 shares of company stock for $331,483 after exercising employee stock options. This transaction occurred on June 30, 2026, with the shares sold at $179.18 each. The sale comes as Globe Life shares are near their 52-week high, with the stock showing a 45% return over the past year, though InvestingPro analysis suggests the stock is currently overvalued.
GLOBE LIFE (NYSE: GL) EVP Skarjune exercises options and sells 1,850 shares
GLOBE LIFE INC. EVP Dolores L. Skarjune exercised employee stock options for 1,850 shares at $103.23 per share and subsequently sold all 1,850 shares in an open-market transaction at $179.18 per share. This "exercise-and-sell" maneuver resulted in a net sale of 1,850 shares for $331,483. After these transactions, Skarjune directly holds 13,696.734 common shares and indirectly holds an additional 2,899.424 shares through a 401(k) plan, with no remaining options from this specific grant.
Globe Life (NYSE: GL) proposed sale of 1,850 shares via option exercise
Globe Life Inc. (NYSE: GL) has filed a Rule 144 notice indicating a proposed sale of 1,850 shares of common stock through a stock option exercise on June 30, 2026. This filing is a procedural step to notify the market of intended transactions under resale restrictions. The notice also reveals that 4,175 shares were sold in the prior three months, generating $693,793.98.
What You Need To Know Ahead of Globe Life's Earnings Release
Globe Life Inc. (GL), an insurance provider, is set to release its Q2 2026 earnings. Analysts project EPS to be $3.66, an 11.9% increase year-over-year, and expect full-year EPS for 2026 and 2027 to show continued growth. Despite missing Q1 2026 revenue and EPS forecasts, GL stock has significantly outperformed the S&P 500 and the XLF ETF over the past 52 weeks, and analysts currently rate it a "Moderate Buy" with potential upside.
Globe Life Extends Credit Facility to 2031 and Upsizes Term Loan to $450 Million
Globe Life has amended and restated its revolving credit facility and term loan, appointing Wells Fargo Bank as Administrative Agent for both. The revolving credit facility's maturity is extended to June 26, 2031, while the term loan is increased to $450 million and extended to June 26, 2029. These actions aim to enhance the company's financial flexibility and align its capital structure with long-term strategic goals.
Globe Life (NYSE: GL) extends credit maturities and boosts $450M term loan
Globe Life Inc. (NYSE: GL) has entered into new credit agreements, extending the maturity dates for its revolving credit facility to June 26, 2031, and its term loan to June 26, 2029. The company also increased its term loan principal amount from $250 million to $450 million and shifted the Administrative Agent role from Bank of America to Wells Fargo Bank, National Association for both facilities. These changes aim to enhance the company's financial flexibility and capital structure.
Aflac turns Rachel Zoe fashion into a cancer-screening push
Aflac has partnered with fashion designer Rachel Zoe to launch "Fit Checks," an awareness campaign aimed at increasing cancer screenings. The campaign features a custom checkered garment with a QR code that links consumers to CheckForCancerNow.com, providing information on cancer risk and early detection. This initiative is part of Aflac's larger "Check for Cancer" movement, which seeks to boost U.S. cancer screenings by 10% over the next decade.
Term Life Insurance from Globe Life Inc. - small monthly premiums for family protection
Globe Life Inc. offers term life insurance with small monthly premiums, designed for simple, entry-level coverage to fit tight household budgets. This core product helps families cover significant obligations like mortgages or education, driving the company's profitability. The application process is straightforward, often not requiring a medical exam, and targets lower and middle-income families with competitive rates, especially for older or slightly less healthy applicants.
Globe Life (GL): Buy, Sell, or Hold Post Q1 Earnings?
Globe Life (GL) has seen a significant stock price increase of 26.2% over the last six months, beating the S&P 500. However, analysts are wary due to tepid long-term revenue growth and disappointing net premiums earned. While the company shows strong recent growth in book value per share, the overall assessment suggests better investment opportunities exist elsewhere given the stock's current valuation.
Globe Life (GL) Is Up 5.0% After Executive Share Sale And Softer Quarter Is Reported - Has The Bull Case Changed?
Globe Life (GL) recently reported a softer quarter with missed earnings and book value per share estimates, and executive Rebecca E. Zorn sold 2,000 shares. Despite this, analysts project a 6.3% sales growth for 2026, leading to a debate on whether the stock's recent strength is backed by fundamentals or vulnerable to regulatory risks. The company also reaffirmed its 2026 earnings guidance and continued share repurchases, with a projected revenue of $6.8 billion and earnings of $1.3 billion by 2028.
Price to earnings forward of Globe Life Inc. – DUS:TMJ
This article provides financial data for Globe Life Inc. (TMJ) on the Dusseldorf Stock Exchange, specifically focusing on its price-to-earnings forward metric. The content highlights the period value, change, and percentage change for this financial indicator but does not include the actual numerical values. It is part of a larger financial data service provided by TradingView.
Globe Life (GL): Buy, Sell, or Hold Post Q1 Earnings?
Globe Life (GL) has seen a significant stock price increase recently, outperforming the S&P 500. However, an analysis suggests caution due to disappointing long-term revenue growth and only moderate net premiums earned, despite strong recent growth in book value per share. The article concludes that while not a terrible business, GL doesn't pass their quality test and better investment opportunities exist elsewhere.
Globe Life (GL) Is Up 5.0% After Executive Share Sale And Softer Quarter Is Reported - Has The Bull Case Changed?
Globe Life (GL) shares rose 5% despite a softer quarter where earnings and book value per share missed estimates, and an executive sold shares. Analysts project a 6.3% sales growth for 2026, anchoring the company's investment narrative. While the capital return stance and sales growth provide support, investors should be aware of ongoing regulatory and investigation risks.
First Community Corp (South Carolina) (FCCO) Institutional Confidence
First Community Corp (FCCO) currently has an institutional shareholding score of 5.00, placing it 164th out of 398 in the Banking Services industry. The institutional shareholding proportion is 53.80%, indicating a 15.86% decrease quarter-over-quarter. James Simons is the largest institutional shareholder, holding 1.33% of the outstanding shares despite a 0.27% decrease in holdings.
The Bull Case For F&G Annuities & Life (FG) Could Change Following CEO Succession Plan And CFO Shift
F&G Annuities & Life (FG) is undergoing a significant leadership transition with CFO Conor Murphy set to become CEO, and Michael Bailey joining as the new CFO. This reshuffle is expected to influence the company's balance between growth, risk management, and capital allocation. Despite these changes, the company maintains its quarterly dividend and continues to focus on areas like RILAs and pension risk transfer, with a projected revenue decrease but earnings increase by 2029.
Globe Life director Alston sells $1.48m in shares
Cheryl Alston, a director at GLOBE LIFE INC. (NASDAQ:GL), sold approximately $1.48 million worth of company common stock on June 25, 2026, after exercising stock options on the same day. She acquired 14,017 shares for $105.56 each and then sold 8,258 shares at prices ranging from $177.5608 to $180.57, near the stock's 52-week high. Alston now directly holds 16,621.037 shares, including those obtained through the dividend reinvestment plan.
The Globe Life Accident Insurance from Globe Life Inc. - fixed cash benefits for everyday injuries
Globe Life Accident Insurance provides fixed cash benefits directly to policyholders for common injuries like fractures and burns, acting as a supplemental policy. This product is a key part of Globe Life Inc.'s portfolio, catering to middle-income households seeking straightforward, accessible insurance coverage for unexpected mishaps. The policy offers clear, scheduled payouts, although benefits are limited to specified events and amounts, and is primarily marketed in the United States.
Globe Life Inc. stock underperforms Friday when compared to competitors despite daily gains
Globe Life Inc. (GL) saw its stock increase by 1.65% on Friday, closing at $179.31, marking its fifth consecutive day of gains. Despite this rise, the company's performance underperformed compared to the broader market, as the S&P 500 Index (SPX) fell by 0.05% and the Dow Jones Industrial Average (DJIA) fell by 0.09% during what was largely a poor trading session.
Form 4 Globe Life Inc For: 26 June By Investing.com
This article provides details on a Form 4 filing for Globe Life Inc. dated June 26. It mentions the company's stock symbol GL and its performance, showing a 1.65% increase. The content indicates the filing is from Investing.com and suggests readers view comments.
Price to sales forward of Globe Life Inc. – NYSE:GL
This article provides financial data on Globe Life Inc. (NYSE: GL), specifically focusing on its price to sales forward metric. It appears to be an excerpt from a financial data platform, presenting basic company information and navigation options related to markets, products, and community features. The core content is very limited, primarily indicating "No trades" and showing a market closed status for GL.
Globe Life (NYSE: GL) director sells 8,258 shares after exercising options
Globe Life (NYSE: GL) director Cheryl Alston exercised options for 14,017 shares at $105.56 per share and subsequently sold 8,258 shares in open-market transactions. The sales occurred on June 25, 2026, with prices ranging from $177.32 to $181.20 per share. After these transactions, Alston directly holds 24,879.037 common shares, which includes shares acquired through the company's dividend reinvestment plan.
Globe Life director Alston sells $1.48m in shares By Investing.com
Cheryl Alston, a director at Globe Life Inc. (NASDAQ:GL), sold approximately $1.48 million worth of company common stock on June 25, 2026, after acquiring shares through an option exercise on the same day. This transaction occurred near the company's 52-week high, with the stock currently trading above its Fair Value according to InvestingPro analysis. Following these sales, Alston directly holds 16,621.037 shares, including those from a dividend reinvestment plan.
Globe Life director Alston sells $1.48m in shares By Investing.com
Cheryl Alston, a director at Globe Life Inc. (NASDAQ:GL), sold approximately $1.48 million worth of company common stock after exercising options to acquire shares. The sales occurred at prices ranging from $177.5608 to $180.57 per share, close to the stock's 52-week high. Following these transactions, Alston directly holds over 16,600 shares, and the company recently reported first-quarter 2026 earnings that slightly missed EPS forecasts but met revenue expectations, leading analysts to adjust price targets positively.
Globe Life Insider Sold Shares Worth $1,480,134, According to a Recent SEC Filing
A recent SEC filing indicates that an insider at Globe Life Inc. sold shares valued at $1,480,134. This transaction follows several other insider share sales reported in recent months for the life and health insurance holding company. Globe Life Inc. also announced a quarterly dividend of $0.33 per share, payable on July 31, 2026.
Globe Life Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.05 Sh
The article provides an overview of Globe Life Inc.'s unsponsored Brazilian Depositary Receipt (G1LL34) on the B3 exchange. It highlights the availability of financial actuals and estimates, allowing users to explore reported financial data and analyst estimates, comparing actuals with average, high, and low estimates, and visualizing trends over time across income statements, balance sheets, and cash flow statements. The content also includes a disclaimer emphasizing that the information is not investment advice.
Price to sales forward of Globe Life Inc. – XETR:TMJ
This article provides the "Price to sales forward" metric for Globe Life Inc., traded on XETRA under the symbol TMJ. The data is presented without specific numerical values but indicates that the information is generated by humans and is available through TradingView's platform.
How Investors May Respond To Globe Life (GL) Executive Stock Sale Amid Strong 2026 Sales Growth Outlook
Globe Life Inc. executive Rebecca E. Zorn sold 2,000 shares in June 2026, coinciding with analysts' strong 2026 sales growth forecast of 6.3% for the insurer. Despite missing recent EPS and book value estimates, the company's resilient sales outlook and ongoing buybacks support a bullish investment narrative, projecting significant revenue and earnings growth by 2028. However, investors are advised to also consider ongoing DOJ and SEC investigations that could impact the company.
Globe Life Liberty National Life Accident Protector from Globe Life Inc. - fixed cash benefits for e
Globe Life Inc. offers the Liberty National Life Accident Protector, a supplemental accident insurance product providing fixed cash benefits directly to policyholders for covered injuries. This policy, designed to complement existing health insurance, helps cover everyday expenses like rent and childcare following an accident. The product, distributed primarily through agents, is a small but stable part of Globe Life's portfolio and contributes to its steady premium income.
ProAssurance is out of the S&P SmallCap 600 as acquisition closes in
NETSTREIT (NYSE: NTST) is set to replace ProAssurance (NYSE: PRA) in the S&P SmallCap 600 index effective before market open on June 29, 2026. This change is due to the pending all-cash acquisition of ProAssurance by The Doctors Company. NETSTREIT will join the index in the Real Estate sector, while ProAssurance is removed from the Financials sector.
Globe Life Insider Sold Shares Worth $1,480,134, According to a Recent SEC Filing
Globe Life Inc. (NYSE: GL) Vice President Michael J. Bischof recently sold 18,272 shares of the company's stock, totaling approximately $1,480,134. This transaction comes after other insider activity over the past year, which saw insiders selling significantly more shares than they purchased. The company's stock has also underperformed, falling 3.5% in the last year compared to the industry's 20.3% gain.
